LATEST ISSUE: Insulin, the next 100 years; diabetes tech update and overview; common digestive disorders
Following last issue’s look at the history of the discovery of insulin, this time we take a good look at what might yet happen. We
Following last issue’s look at the history of the discovery of insulin, this time we take a good look at what might yet happen. We
Tandem is first smartphone App to be cleared for insulin delivery by the FDA on both iOS and Android operating systems. Announced in mid-February 2022,
The American medical devices giant Becton Dickinson known as BD, has decided to spin off its Diabetes Care division and announced the name of the
Latest results from the makers of Revita, the revolutionary ‘intestine resurfacing’ device being proposed as a treatment for T2D, offer a glimmer of light in
Insulin pump manufacturer Insulet has announced their new Omnipod 5 device has at last received regulatory approval from the American Food and Drug Administration (FDA)
Tandem Diabetes Care has announced that it expects to treble its worldwide customer base to one million people within the next five years, mainly by
Researchers have now homed in on four factors which may trigger the worrying rise in diabetes diagnoses following COVID-19 infection, according to the American Diabetes
As of 100 years ago, a diagnosis of Type 1 diabetes ceased to be a death sentence. Seeing all the coverage of the amazing, life-saving
Immunotherapies are new treatments that reprogramme the immune system so that it no longer attacks and destroys insulin-producing cells in the pancreas. They’re being tested
The sooner children with Type 1 diabetes are given the latest treatment devices the greater the benefit, according to research by Stanford University in America.